Schouw & Co (SCHO) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
5 Mar, 2026Executive summary
Delivered solid performance despite a turbulent environment, maintaining a 5-year growth streak with revenue CAGR of 9% and EBITDA CAGR of 7%.
Revenue for 2025 was DKK 34.1 billion, with EBITDA at DKK 2.88 billion, including DKK 100 million in one-off costs.
Cash flow reached a record DKK 2.9 billion, with cash conversion around 100%.
Net Interest-Bearing Debt (NIBD) reduced to DKK 4.4 billion, leverage at 1.5x.
Emissions (CO2e, scope 1+2) reduced by 8% p.a.; lost time injury frequency rate down 5% p.a.
Financial highlights
Five out of six companies achieved EBITDA uplift; one-off goodwill impairment of DKK 299–300 million at Borg.
Net working capital reduced by DKK 927 million, mainly through inventory reduction.
EBIT and profit before tax negatively impacted by impairment.
CapEx maintained at low but sufficient levels, with net investments of DKK 952 million.
Shareholder distributions totaled DKK 577 million.
Outlook and guidance
2026 group EBITDA expected at DKK 2.9–3.2 billion, with profit uplift in five out of six companies.
2026 revenue guidance: DKK 33.0–35.5 billion.
CapEx budgeted at DKK 700–900 million, mainly for BioMar’s Ecuador shrimp market expansion; capex to remain at 2.0–2.6% of revenue.
Continued focus on capital discipline, cash flow, and reducing net working capital.
All major business units guided for stable or improved EBITDA in 2026.
Latest events from Schouw & Co
- EBITDA guidance raised as margin gains offset revenue decline amid market headwinds.SCHO
Q2 20241 Feb 2026 - Revenue and EBITDA fell, but margins and cash flow held; BioMar IPO and cost cuts in focus.SCHO
Q3 202415 Jan 2026 - EBITDA rose 3% to DKK 2.93bn despite a 7% revenue drop, with strong cash flow and lower debt.SCHO
Q4 202423 Dec 2025 - Q1 2025 revenue up 1%, EBITDA down 13%, guidance maintained, BioMar IPO prep advances.SCHO
Q1 202529 Nov 2025 - Stable Q2 with strong cash flow and narrowed guidance; segment outlooks mixed amid volatility.SCHO
Q2 202523 Nov 2025 - EBITDA rose 5% despite a 4% revenue drop, with narrowed guidance and ongoing restructuring.SCHO
Q3 202512 Nov 2025